Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000913849-17-000035
Filing Date
2017-02-10
Accepted
2017-02-10 16:25:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 2 sc13ga_020917.htm SC 13G/A 42290
  Complete submission text file 0000913849-17-000035.txt   43879
Mailing Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601
Business Address 222 NORTH LASALLE STREET SUITE 2000 CHICAGO IL 60601 312-899-5034
CVF, LLC (Filed by) CIK: 0001112278 (see all company filings)

IRS No.: 367227242
Type: SC 13G/A

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Subject) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88094 | Film No.: 17593694
SIC: 2834 Pharmaceutical Preparations